Sept 30 (Reuters) - AstraZeneca Canada:
* HEALTH CANADA APPROVED EXPANDED USE OF SYMBICORT TURBUHALER FOR TREATMENT OF MILD PERSISTENT ASTHMA IN PATIENTS 12 YRS & OLDER
* SYMBICORT TURBUHALER APPROVED AS ANTI-INFLAMMATORY RELIEVER IN CANADA FOR USE IN MILD PERSISTENT, MODERATE, OR SEVERE ASTHMA PATIENTS